These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 19489232

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
    Helczynska K, Kronblad A, Jögi A, Nilsson E, Beckman S, Landberg G, Påhlman S.
    Cancer Res; 2003 Apr 01; 63(7):1441-4. PubMed ID: 12670886
    [Abstract] [Full Text] [Related]

  • 24. Microsatellite instability in ductal carcinoma in situ of the breast.
    Walsh T, Chappell SA, Shaw JA, Walker RA.
    J Pathol; 1998 May 01; 185(1):18-24. PubMed ID: 9713355
    [Abstract] [Full Text] [Related]

  • 25. New method to predict DCIS recurrence.
    Printz C.
    Cancer; 2013 Nov 15; 119(22):3899. PubMed ID: 24590902
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
    DeCensi A, Pruneri G, Guerrieri-Gonzaga A.
    J Clin Oncol; 2012 Apr 20; 30(12):1384-6. PubMed ID: 22393083
    [No Abstract] [Full Text] [Related]

  • 30. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways.
    Buerger H, Otterbach F, Simon R, Poremba C, Diallo R, Decker T, Riethdorf L, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W.
    J Pathol; 1999 Mar 20; 187(4):396-402. PubMed ID: 10398097
    [Abstract] [Full Text] [Related]

  • 31. [Detection and clinical significance of Notch1 methylation in breast cancer and intraductal proliferative breast lesions].
    Zhang N, Sun ZZ, Li F, Cao YW, Zhao CX, Liang WH, Sun HP, Li HA, Fu XG.
    Zhonghua Bing Li Xue Za Zhi; 2011 May 20; 40(5):324-9. PubMed ID: 21756827
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A SAGE (serial analysis of gene expression) view of breast tumor progression.
    Porter DA, Krop IE, Nasser S, Sgroi D, Kaelin CM, Marks JR, Riggins G, Polyak K.
    Cancer Res; 2001 Aug 01; 61(15):5697-702. PubMed ID: 11479200
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Cystic hypersecretory carcinoma with microinvasive carcinoma and cystic hypersecretory hyperplasia of breast: report of a case].
    Chen DB, Kan X.
    Zhonghua Bing Li Xue Za Zhi; 2010 Jan 01; 39(1):54-5. PubMed ID: 20388402
    [No Abstract] [Full Text] [Related]

  • 37. A high-risk lesion for invasive breast cancer, ductal carcinoma in situ, exhibits frequent overexpression of retinoid X receptor.
    Lawrence JA, Merino MJ, Simpson JF, Manrow RE, Page DL, Steeg PS.
    Cancer Epidemiol Biomarkers Prev; 1998 Jan 01; 7(1):29-35. PubMed ID: 9456240
    [Abstract] [Full Text] [Related]

  • 38. Molecular evidence for progression of microglandular adenosis (MGA) to invasive carcinoma.
    Shin SJ, Simpson PT, Da Silva L, Jayanthan J, Reid L, Lakhani SR, Rosen PP.
    Am J Surg Pathol; 2009 Apr 01; 33(4):496-504. PubMed ID: 19047897
    [Abstract] [Full Text] [Related]

  • 39. Molecular characterization of the tumor microenvironment in breast cancer.
    Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, Porter D, Hu M, Chin L, Richardson A, Schnitt S, Sellers WR, Polyak K.
    Cancer Cell; 2004 Jul 01; 6(1):17-32. PubMed ID: 15261139
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.